T2 Biosystems (TTOO) Competitors $0.18 -0.05 (-22.08%) As of 02/21/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TTOO vs. CTCX, CHEK, TNON, SINT, HSCS, AMIX, NDRA, GMVDF, BBLG, and VEROShould you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include Carmell (CTCX), Check-Cap (CHEK), Tenon Medical (TNON), Sintx Technologies (SINT), Heart Test Laboratories (HSCS), Autonomix Medical (AMIX), ENDRA Life Sciences (NDRA), G Medical Innovations (GMVDF), Bone Biologics (BBLG), and Venus Concept (VERO). These companies are all part of the "medical equipment" industry. T2 Biosystems vs. Carmell Check-Cap Tenon Medical Sintx Technologies Heart Test Laboratories Autonomix Medical ENDRA Life Sciences G Medical Innovations Bone Biologics Venus Concept Carmell (NASDAQ:CTCX) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, community ranking, valuation, media sentiment, analyst recommendations, dividends and earnings. Do insiders and institutionals hold more shares of CTCX or TTOO? 24.2% of Carmell shares are owned by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are owned by institutional investors. 29.0% of Carmell shares are owned by insiders. Comparatively, 0.0% of T2 Biosystems shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is CTCX or TTOO more profitable? Carmell has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%. T2 Biosystems' return on equity of 0.00% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets CarmellN/A -217.50% -50.22% T2 Biosystems -563.16%N/A -174.06% Which has stronger earnings & valuation, CTCX or TTOO? Carmell has higher earnings, but lower revenue than T2 Biosystems. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCarmellN/AN/A-$15.44MN/AN/AT2 Biosystems$7.19M0.53-$50.08MN/AN/A Which has more volatility and risk, CTCX or TTOO? Carmell has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 0.35, meaning that its stock price is 65% less volatile than the S&P 500. Does the media refer more to CTCX or TTOO? In the previous week, T2 Biosystems had 4 more articles in the media than Carmell. MarketBeat recorded 4 mentions for T2 Biosystems and 0 mentions for Carmell. Carmell's average media sentiment score of 0.00 beat T2 Biosystems' score of -0.30 indicating that Carmell is being referred to more favorably in the media. Company Overall Sentiment Carmell Neutral T2 Biosystems Neutral Does the MarketBeat Community believe in CTCX or TTOO? T2 Biosystems received 406 more outperform votes than Carmell when rated by MarketBeat users. CompanyUnderperformOutperformCarmellN/AN/AT2 BiosystemsOutperform Votes40663.24% Underperform Votes23636.76% Do analysts recommend CTCX or TTOO? T2 Biosystems has a consensus price target of $5.00, indicating a potential upside of 2,677.78%. Given T2 Biosystems' stronger consensus rating and higher probable upside, analysts plainly believe T2 Biosystems is more favorable than Carmell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Carmell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00T2 Biosystems 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryCarmell beats T2 Biosystems on 7 of the 13 factors compared between the two stocks. Get T2 Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TTOO vs. The Competition Export to ExcelMetricT2 BiosystemsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.86M$4.61B$5.81B$9.02BDividend YieldN/A39.91%4.77%3.84%P/E RatioN/A24.1021.5016.68Price / Sales0.5350.59453.1985.13Price / CashN/A51.2243.9637.32Price / Book-0.036.577.654.65Net Income-$50.08M$90.13M$3.18B$245.69M7 Day PerformanceN/A-2.20%-1.95%-2.67%1 Month Performance-21.47%-2.17%-0.23%-2.16%1 Year Performance-96.72%15.26%16.69%12.90% T2 Biosystems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TTOOT2 Biosystems1.9716 of 5 stars$0.18-22.1%$5.00+2,677.8%-96.8%$4.86M$7.19M0.00180Analyst ForecastNews CoverageCTCXCarmellN/A$0.25+2.5%N/A-92.2%$5.14MN/A0.0014CHEKCheck-Cap0.4585 of 5 stars$0.86-4.3%N/A-68.1%$5.04MN/A-0.2980Analyst ForecastTNONTenon Medical1.6955 of 5 stars$1.46flat$5.50+276.7%+23.0%$4.58M$2.93M-0.058SINTSintx Technologies1.0193 of 5 stars$2.95-0.7%N/A-82.2%$3.95M$2.63M-0.0640News CoverageHSCSHeart Test Laboratories2.4753 of 5 stars$3.91+2.6%$13.50+245.3%-69.2%$3.83M$20,000.00-0.4910Positive NewsGap DownAMIXAutonomix Medical1.8698 of 5 stars$2.84-0.4%$28.00+885.9%-96.2%$3.27MN/A-0.181News CoverageNDRAENDRA Life Sciences2.344 of 5 stars$5.02+0.1%$700,000.00+13,958,025.6%-100.0%$2.71MN/A-0.0120Gap UpGMVDFG Medical InnovationsN/AN/AN/A-99.3%$2.60M$4.42M0.0072BBLGBone Biologics0.2322 of 5 stars$1.04+1.0%N/A-67.9%$2.59MN/A0.002VEROVenus ConceptN/A$0.33-1.0%N/A-74.6%$2.41M$76.35M-0.04410Negative News Related Companies and Tools Related Companies Carmell Competitors Check-Cap Competitors Tenon Medical Competitors Sintx Technologies Competitors Heart Test Laboratories Competitors Autonomix Medical Competitors ENDRA Life Sciences Competitors G Medical Innovations Competitors Bone Biologics Competitors Venus Concept Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TTOO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T2 Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share T2 Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.